🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.810
-0.100 (-5.24%)
At close: Nov 20, 2026, 4:00 PM EST
1.690
-0.120 (-6.63%)
After-hours: Nov 20, 2026, 7:59 PM EST

GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $985,460. The enterprise value is -$915,033.

Market Cap985,460
Enterprise Value -915,033

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

GeoVax Labs has 544,453 shares outstanding. The number of shares has increased by 617.68% in one year.

Current Share Class 544,453
Shares Outstanding 544,453
Shares Change (YoY) +617.68%
Shares Change (QoQ) +106.90%
Owned by Insiders (%) 4.22%
Owned by Institutions (%) 6.40%
Float 355,948

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.66
P/TBV Ratio 0.86
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.22.

Current Ratio 1.46
Quick Ratio 1.01
Debt / Equity 0.22
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -603.27% and return on invested capital (ROIC) is -363.42%.

Return on Equity (ROE) -603.27%
Return on Assets (ROA) -225.63%
Return on Invested Capital (ROIC) -363.42%
Return on Capital Employed (ROCE) -1,422.00%
Weighted Average Cost of Capital (WACC) 20.32%
Revenue Per Employee n/a
Profits Per Employee -$961,206
Employee Count19
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.27% in the last 52 weeks. The beta is 3.86, so GeoVax Labs's price volatility has been higher than the market average.

Beta (5Y) 3.86
52-Week Price Change -99.27%
50-Day Moving Average 5.76
200-Day Moving Average 25.27
Relative Strength Index (RSI) 16.06
Average Volume (20 Days) 625,442

Short Selling Information

The latest short interest is 175,903, so 32.31% of the outstanding shares have been sold short.

Short Interest 175,903
Short Previous Month 270,211
Short % of Shares Out 32.31%
Short % of Float 49.42%
Short Ratio (days to cover) 0.21

Income Statement

Revenue n/a
Gross Profit -12.83M
Operating Income -18.33M
Pretax Income -18.26M
Net Income -18.26M
EBITDA -18.28M
EBIT -18.33M
Earnings Per Share (EPS) -$98.30
Full Income Statement

Balance Sheet

The company has $2.15 million in cash and $250,453 in debt, with a net cash position of $1.90 million or $3.49 per share.

Cash & Cash Equivalents 2.15M
Total Debt 250,453
Net Cash 1.90M
Net Cash Per Share $3.49
Equity (Book Value) 1.15M
Book Value Per Share 2.73
Working Capital 978,595
Full Balance Sheet

Cash Flow

Operating Cash Flow -16.50M
Capital Expenditures n/a
Depreciation & Amortization 50,924
Net Borrowing n/a
Free Cash Flow -16.50M
FCF Per Share -$30.30
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -617.68%
Shareholder Yield -617.68%
Earnings Yield -5,431.19%
FCF Yield -1,674.17%

Analyst Forecast

The average price target for GeoVax Labs is $240.00, which is 13,159.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target $240.00
Price Target Difference 13,159.67%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on November 11, 2026. It was a reverse split with a ratio of 1:24.

Last Split Date Nov 11, 2026
Split Type Reverse
Split Ratio 1:24

Scores

GeoVax Labs has an Altman Z-Score of -82.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -82.83
Piotroski F-Score 1